Skip to main content

Table 1 Demographics of populations

From: The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline

  Safety Population (n = 646) Efficacy Population (n = 592)
Age (yrs) 34.8 (6 to 83) 34.7 (6 to 83)
Gender 47% M: 53% F 46% M: 54% F
Race 91% Caucasian 91% Caucasian
BMI (kg/m2) 25.5 (0.6) 25.5 (0.6)
Height (cm) 164.2 (14.0) 164.3 (13.9)
Weight (kg) 70.2 (21.6) 70.1 (21.6)
Asthmatics (n) 551 505
FEV1 (L) 3.0 (0.9) 3.0 (0.9)
% Predicted FEV1 95.0 (14.5) 95.5 (14.7)
Non-asthmatics (n) 95 91
FEV1 (L) 3.2 (0.9) 3.2 (0.9)
% Predicted FEV1 94.6 (14.1) 95.2 (14.4)